Vivek Ramaswamy

Overview

Vivek Ramaswamy is an American entrepreneur and investor recognized for his significant contributions to the biotechnology and media industries. He founded Roivant Sciences in 2014, a biopharmaceutical company focused on developing and commercializing innovative therapies. Under his leadership, Roivant Sciences established several subsidiaries, including Dermavant and Urovant, targeting dermatology and urology, respectively. In 2021, Ramaswamy transitioned from CEO to executive chairman of Roivant Sciences to concentrate on other ventures. In 2022, Ramaswamy co-founded Strive Asset Management, an investment firm that manages over $1.6 billion in assets. The firm positions itself as an alternative to traditional ESG-focused funds, emphasizing shareholder primacy and corporate excellence. Strive Asset Management has attracted investments from notable figures such as Peter Thiel, JD Vance, and Bill Ackman. Ramaswamy's investment portfolio is diverse, encompassing stakes in companies like Rumble Inc., a video-sharing platform, and MoonPay, a cryptocurrency payment service. Additionally, he has invested in cryptocurrencies, including Bitcoin and Ethereum. Ramaswamy's entrepreneurial journey is marked by his commitment to innovation and his critical stance on corporate social responsibility initiatives. His ventures reflect a strategic approach to identifying and capitalizing on market opportunities across various sectors, including biotechnology, media, and technology. His investments and business decisions continue to influence the landscape of these industries, underscoring his role as a prominent figure in the American entrepreneurial ecosystem.

Investment Focus

• Focus on innovative and high-growth potential companies
• Alignment with shareholder primacy and corporate excellence principles
• Opportunities in biotechnology, media, technology, healthcare, and financial services sectors

Portfolio Companies